180 related articles for article (PubMed ID: 26078096)
1. Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy.
Chou YS; Yang MH
J Chin Med Assoc; 2015 Aug; 78(8):438-45. PubMed ID: 26078096
[TBL] [Abstract][Full Text] [Related]
2. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas.
Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Miyake H
J Gastroenterol Hepatol; 2014 Dec; 29(12):2032-7. PubMed ID: 24909638
[TBL] [Abstract][Full Text] [Related]
3. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
Wu KJ
Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
5. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
6. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
7. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
8. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
9. Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications.
Wu CY; Hung JJ; Wu KJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):668-73. PubMed ID: 21883379
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
Wu KJ; Yang MH
Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
[TBL] [Abstract][Full Text] [Related]
11. Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.
Hatta M; Miyake Y; Uchida K; Yamazaki J
Biochem Biophys Res Commun; 2018 Feb; 496(2):381-386. PubMed ID: 29326042
[TBL] [Abstract][Full Text] [Related]
12. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
14. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
15. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
16. AKT-ions with a TWIST between EMT and MET.
Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
19. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
[TBL] [Abstract][Full Text] [Related]
20. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET.
Goossens S; Vandamme N; Van Vlierberghe P; Berx G
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):584-591. PubMed ID: 28669750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
